Found 4 matching trials
BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
PHASE2The primary objective of the study is to assess the efficacy of Intravenous...
Study of the Safety, Tolerability, Pharmacokinetics and Safety of BG00010 (Neublastin) in Subjects With Sciatica.
PHASE1The primary objective of the study is to evaluate the safety, tolerability,...
Phase 1 Subcutaneous Single and Multiple Ascending Dose Study of BG00010 (Neublastin)
PHASE1The primary objective of the study is to evaluate the safety and tolerabili...
Location
Center for Human Drug Research
Evaluate the Safety, Tolerability and Pharmacokinetics of BG00010 (Neublastin) Administered to Sciatica Participants
PHASE1The primary objective of the study is to determine the safety/tolerability ...